Arrowhead Pharmaceuticals, Inc. (ARWR) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 73.74M | 264.03M | 256.47M | 27.77M | 542.71M | 2.5M | 0 | 0 | 0 | 3.55M | 16.1M | 15.82M |
| Revenue Growth % | -86.41% | 10461.32% | - | - | - | -29.6% | -100% | -100% | -100% | -94.32% | -49.02% | -51.18% |
| Cost of Goods Sold | 6.37M | 0 | 0 | 0 | 0 | 0 | 5.03M | 4.78M | 4.53M | 4.26M | 3.86M | 3.27M |
| COGS % of Revenue | 8.64% | - | - | - | - | - | - | - | - | 120.05% | 23.97% | 20.7% |
| Gross Profit | 67.37M | 264.03M | 256.47M | 27.77M | 542.71M | 2.5M | -5.03M | -4.78M | -4.53M | -712K | 12.24M | 12.55M |
| Gross Margin % | 91.36% | 100% | 100% | 100% | 100% | 100% | - | - | - | -20.05% | 76.03% | 79.3% |
| Gross Profit Growth % | -87.59% | 10461.32% | 5203.92% | 680.66% | 12093.57% | 451.12% | -141.06% | -138.1% | -103.15% | -101.19% | -57.68% | -57.9% |
| Operating Expenses | 208.63M | 223.22M | 212.37M | 193.32M | 161.51M | 163.91M | 157.18M | 171.36M | 121.67M | 135.83M | 120.57M | 115.25M |
| OpEx % of Revenue | 282.94% | 84.54% | 82.8% | 696.21% | 29.76% | 6556.48% | - | - | - | 3825.2% | 749.01% | 728.3% |
| Selling, General & Admin | 41.24M | 45.52M | 37.18M | 30.44M | 27.89M | 26.4M | 25.79M | 23.2M | 24.64M | 23.19M | 24.17M | 23.37M |
| SG&A % of Revenue | 55.93% | 17.24% | 14.5% | 109.64% | 5.14% | 1056.04% | - | - | - | 653.14% | 150.13% | 147.66% |
| Research & Development | 167.38M | 177.2M | 174.69M | 162.37M | 133.1M | 137M | 131.39M | 148.16M | 97.02M | 112.64M | 96.4M | 91.89M |
| R&D % of Revenue | 227% | 67.11% | 68.11% | 584.75% | 24.53% | 5480.08% | - | - | - | 3172.06% | 598.88% | 580.64% |
| Other Operating Expenses | 0 | 504K | 503K | 505K | 511K | 509K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -141.26M | 40.81M | 44.11M | -165.55M | 381.2M | -161.41M | -162.2M | -176.14M | -126.19M | -136.54M | -108.33M | -102.7M |
| Operating Margin % | -191.57% | 15.46% | 17.2% | -596.21% | 70.24% | -6456.48% | - | - | - | -3845.25% | -672.98% | -648.99% |
| Operating Income Growth % | -137.06% | 125.28% | 127.19% | 6.01% | 402.08% | -18.21% | -49.73% | -71.51% | -362% | -224.07% | -29.23% | -40.86% |
| EBITDA | -134.89M | 47.2M | 50.49M | -159.33M | 387.29M | -156.18M | -157.18M | -171.36M | -121.67M | -132.28M | -104.47M | -99.43M |
| EBITDA Margin % | -182.94% | 17.88% | 19.69% | -573.8% | 71.36% | -6247.08% | - | - | - | -3725.2% | -649.01% | -628.29% |
| EBITDA Growth % | -134.83% | 130.22% | 132.12% | 7.02% | 418.32% | -18.06% | -50.45% | -72.35% | -339.34% | -235.36% | -28.71% | -41.4% |
| D&A (Non-Cash Add-back) | 6.37M | 6.39M | 6.39M | 6.22M | 6.08M | 5.24M | 5.03M | 4.78M | 4.53M | 4.26M | 3.86M | 3.28M |
| EBIT | -141.26M | 50.78M | 57.81M | -154.71M | 391.25M | -153.47M | -158.15M | -168.88M | -119.75M | -133.32M | -103.73M | -98.22M |
| Net Interest Income | -6.98M | -12.81M | -12.64M | -13.36M | -12.02M | -14.04M | -7.48M | 1.4M | -994K | -2.56M | -1.38M | -986K |
| Interest Income | 16.87M | 9.69M | 9.05M | 11.02M | 9.62M | 7.6M | 7.17M | 6.5M | 6.25M | 2.8M | 3.88M | 4.17M |
| Interest Expense | 23.85M | 22.5M | 21.69M | 24.38M | 21.64M | 21.65M | 14.65M | 5.09M | 7.24M | 5.37M | 5.26M | 5.16M |
| Other Income/Expense | 3.69M | -12.54M | -7.99M | -13.54M | -11.59M | -13.7M | -10.6M | 2.16M | -805K | -2.14M | -660K | -680K |
| Pretax Income | -137.56M | 28.27M | 36.12M | -179.09M | 369.62M | -175.12M | -172.8M | -173.98M | -127M | -138.69M | -108.99M | -103.38M |
| Pretax Margin % | -186.56% | 10.71% | 14.08% | -644.97% | 68.11% | -7004.6% | - | - | - | -3905.63% | -677.08% | -653.29% |
| Income Tax | 7K | 29K | 20M | -437K | 1.75M | 103K | 546K | 0 | 0 | -3.31M | 2.02M | 742K |
| Effective Tax Rate % | -0.01% | 0.1% | 55.37% | 0.24% | 0.47% | -0.06% | -0.32% | 0% | 0% | 2.39% | -1.86% | -0.72% |
| Net Income | -132.73M | 30.81M | -23.75M | -175.24M | 370.44M | -173.09M | -170.54M | -170.79M | -125.3M | -132.86M | -109.68M | -102.95M |
| Net Margin % | -180.01% | 11.67% | -9.26% | -631.11% | 68.26% | -6923.4% | - | - | - | -3741.59% | -681.36% | -650.53% |
| Net Income Growth % | -135.83% | 117.8% | 86.07% | -2.6% | 395.65% | -30.27% | -55.49% | -65.91% | -357.42% | -221.51% | -28.26% | -42.89% |
| Net Income (Continuing) | -137.57M | 28.24M | 16.12M | -178.65M | 367.86M | -175.22M | -173.34M | -173.98M | -127M | -135.38M | -111.02M | -104.13M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -15.06M | -5.72M | 37.36M | -2.51M | 904K | 3.49M | 5.62M | 8.43M | 11.61M | 13.31M | 15.82M | 17.16M |
| EPS (Diluted) | -0.93 | 0.22 | -0.17 | -1.26 | 2.75 | -1.39 | -1.40 | -1.38 | -1.02 | -1.24 | -1.02 | -0.96 |
| EPS Growth % | -133.82% | 115.83% | 87.86% | 8.7% | 369.61% | -12.1% | -37.25% | -43.75% | -326.67% | -217.95% | -25.93% | -43.28% |
| EPS (Basic) | -0.93 | 0.22 | -0.17 | -1.26 | 2.78 | -1.39 | -1.40 | -1.38 | -1.02 | -1.24 | -1.02 | -0.96 |
| Diluted Shares Outstanding | 142.42M | 140.71M | 135.7M | 139.04M | 134.48M | 124.85M | 121.99M | 124.2M | 123.28M | 107.42M | 107.31M | 107M |
| Basic Shares Outstanding | 142.42M | 140.05M | 135.7M | 139.04M | 133.36M | 124.85M | 121.99M | 124.2M | 123.28M | 107.42M | 107.31M | 107M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |